Anthracenes
Search Within Results
151
–
165
of
310
results
151
![Medchemexpress LLC (2S)-N-[7-chloro-6-[4-[(3R,4R)-4-hydroxy-3-methyloxolan-3-yl]piperazin-1-yl]isoquinolin-3-yl]-6-o... | 2769107-89-1 | 99.7% | 501.02 g·mol⁻1 | C26H33ClN4O4 | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000288091.png-250.jpg)
Medchemexpress LLC (2S)-N-[7-chloro-6-[4-[(3R,4R)-4-hydroxy-3-methyloxolan-3-yl]piperazin-1-yl]isoquinolin-3-yl]-6-o... | 2769107-89-1 | 99.7% | 501.02 g·mol⁻1 | C26H33ClN4O4 | 10 MG
MK-1468 is an orally active, selective, blood-brain barrier-permeable inhibitor of leucine-rich repeat kinase 2 (LRRK2) used in preclinical research of Parkinson's disease and LRRK2-related pathways.
- Orally active and brain-penetrant LRRK2 inhibitor suitable for in vivo and in vitro studies.
- High purity (≈99.7%) for research-grade experiments.
- Molecular weight 501.02 g·mol⁻1 and formula C26H33ClN4O4.
- Available in small-scale quantities for dosing and assay optimization.
- Store powder at -20°C; solutions stable at -80°C for 6 months.
152
eMolecules Target Molecule TAK-779 5mg 517682755 T7499 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
Target Molecule TAK-779 5mg 517682755 T7499 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
153
eMolecules Target Molecule TAK-779 25mg 517682757 T7499 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
Target Molecule TAK-779 25mg 517682757 T7499 0 000 229005-80-5 MFCD05662319 531 140 C33H39ClN2O2
154
TARGETMOL CHEMICALS INC A 779 TFA159432-28-7 FRE 25MG
Also available in 1 mg 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. A 779 TFA is a potent antagonist of angiotensin-(1-7) receptor.
155
156
157
158
159
160
161
162
163
164
165